In MDS/AML, DDX41 is thought to interact with spliceosomal components and alter splicing, resulting in the inactivation of tumor suppressor genes or alterations in the balance of gene isoforms, although whether this occurs through protein-RNA, protein-DNA, or protein-protein interactions is not known. The gene discussed is DDX41; the disease is myelodysplastic syndrome.